Global CRISPR and CRISPR-Associated (Cas) Genes Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 CRISPR and CRISPR-Associated (Cas) Genes Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type
  • 1.4.2 Genome Editing
  • 1.4.3 Genetic Engineering
  • 1.2.4 gRNA Database/Gene Librar
  • 1.2.5 CRISPR Plasmid
  • 1.2.6 Human Stem Cells
  • 1.2.7 Genetically Modified Organisms/Crops
  • 1.2.8 Cell Line Engineering
• 1.3 Market by Application
  • 1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Application
  • 1.3.2 Biotechnology Companies
  • 1.3.3 Pharmaceutical Companies
  • 1.3.4 Academic Institutes
  • 1.3.5 Research and Development Institutes
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Estimates and Forecasts 2016-2027
• 2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Estimates and Forecasts 2016-2027
• 2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Sales
  • 2.4.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Sales (2016-2021)
  • 2.4.2 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Sales (2022-2027)
• 2.5 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Revenue
  • 2.5.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Revenue (2016-2021)
  • 2.5.2 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Manufacturers
  • 3.1.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top CRISPR and CRISPR-Associated (Cas) Genes Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Sales in 2020
• 3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Manufacturers
  • 3.2.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top CRISPR and CRISPR-Associated (Cas) Genes Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2020
• 3.3 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global CRISPR and CRISPR-Associated (Cas) Genes Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Type
  • 4.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historical Sales by Type (2016-2021)
  • 4.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2027)
• 4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type
  • 4.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historical Revenue by Type (2016-2021)
  • 4.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2016-2027)
• 4.3 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Type
  • 4.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Type (2016-2021)
  • 4.3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Application
  • 5.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historical Sales by Application (2016-2021)
  • 5.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2027)
• 5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application
  • 5.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historical Revenue by Application (2016-2021)
  • 5.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2016-2027)
• 5.3 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Application
  • 5.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Application (2016-2021)
  • 5.3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
  • 6.1.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2027)
  • 6.1.2 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2016-2027)
• 6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
  • 6.2.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2027)
  • 6.2.2 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2016-2027)
• 6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
  • 6.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2016-2027)
  • 6.3.2 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
  • 7.1.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2017-2027)
  • 7.1.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2017-2027)
• 7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
  • 7.2.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2017-2027)
  • 7.2.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2017-2027)
• 7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
  • 7.3.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2017-2027)
  • 7.3.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
  • 8.1.1 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2018-2027)
• 8.2 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
  • 8.2.1 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2018-2027)
• 8.3 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region
  • 8.3.1 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
  • 9.1.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2019-2027)
  • 9.1.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2019-2027)
• 9.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
  • 9.2.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2019-2027)
  • 9.2.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2019-2027)
• 9.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
  • 9.3.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2019-2027)
  • 9.3.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
  • 6.1.1 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2016-2027)
• 6.2 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
  • 6.2.1 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2016-2027)
• 6.3 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
  • 6.3.1 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 Caribou Biosciences
  • 11.1.1 Caribou Biosciences Corporation Information
  • 11.1.2 Caribou Biosciences Overview
  • 11.1.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Description
  • 11.1.5 Caribou Biosciences Related Developments
• 11.2 Addgene
  • 11.2.1 Addgene Corporation Information
  • 11.2.2 Addgene Overview
  • 11.2.3 Addgene CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 Addgene CRISPR and CRISPR-Associated (Cas) Genes Product Description
  • 11.2.5 Addgene Related Developments
• 11.3 CRISPR THERAPEUTICS
  • 11.3.1 CRISPR THERAPEUTICS Corporation Information
  • 11.3.2 CRISPR THERAPEUTICS Overview
  • 11.3.3 CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Product Description
  • 11.3.5 CRISPR THERAPEUTICS Related Developments
• 11.4 Merck KGaA
  • 11.4.1 Merck KGaA Corporation Information
  • 11.4.2 Merck KGaA Overview
  • 11.4.3 Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Product Description
  • 11.4.5 Merck KGaA Related Developments
• 11.5 Mirus Bio LLC
  • 11.5.1 Mirus Bio LLC Corporation Information
  • 11.5.2 Mirus Bio LLC Overview
  • 11.5.3 Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Product Description
  • 11.5.5 Mirus Bio LLC Related Developments
• 11.6 Editas Medicine
  • 11.6.1 Editas Medicine Corporation Information
  • 11.6.2 Editas Medicine Overview
  • 11.6.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Description
  • 11.6.5 Editas Medicine Related Developments
• 11.7 Takara Bio USA
  • 11.7.1 Takara Bio USA Corporation Information
  • 11.7.2 Takara Bio USA Overview
  • 11.7.3 Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Product Description
  • 11.7.5 Takara Bio USA Related Developments
• 11.8 Thermo Fisher Scientific
  • 11.8.1 Thermo Fisher Scientific Corporation Information
  • 11.8.2 Thermo Fisher Scientific Overview
  • 11.8.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Description
  • 11.8.5 Thermo Fisher Scientific Related Developments
• 11.9 Horizon Discovery Group
  • 11.9.1 Horizon Discovery Group Corporation Information
  • 11.9.2 Horizon Discovery Group Overview
  • 11.9.3 Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Product Description
  • 11.9.5 Horizon Discovery Group Related Developments
• 11.10 Intellia Therapeutics
  • 11.10.1 Intellia Therapeutics Corporation Information
  • 11.10.2 Intellia Therapeutics Overview
  • 11.10.3 Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Description
  • 11.10.5 Intellia Therapeutics Related Developments
• 11.1 Caribou Biosciences
  • 11.1.1 Caribou Biosciences Corporation Information
  • 11.1.2 Caribou Biosciences Overview
  • 11.1.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Description
  • 11.1.5 Caribou Biosciences Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 CRISPR and CRISPR-Associated (Cas) Genes Value Chain Analysis
• 12.2 CRISPR and CRISPR-Associated (Cas) Genes Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 CRISPR and CRISPR-Associated (Cas) Genes Production Mode & Process
• 12.4 CRISPR and CRISPR-Associated (Cas) Genes Sales and Marketing
  • 12.4.1 CRISPR and CRISPR-Associated (Cas) Genes Sales Channels
  • 12.4.2 CRISPR and CRISPR-Associated (Cas) Genes Distributors
• 12.5 CRISPR and CRISPR-Associated (Cas) Genes Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
• 13.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
• 13.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
• 13.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints

14 Key Findings in The Global CRISPR and CRISPR-Associated (Cas) Genes Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details